7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Coya Therapeutics Inc.
(NASDAQ:COYA) 


Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs).

Founded: 2020
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends
Coya Therapeutics Days Payable Outstanding ttm (DPO)
202403 202404 02.24.46.618.8111.0113.2115.42Thousand
Coya Therapeutics Days Receivable Outstanding ttm (DSO)
202403 202404 065.15130.31195.46260.62325.77390.93456.08
Coya Therapeutics Op Cashflow Per Share ttm
202403 202404 -0.78-0.67-0.55-0.44-0.33-0.22-0.110
Coya Therapeutics Free Cashflow Per Share ttm
202403 202404 -0.78-0.67-0.55-0.44-0.33-0.22-0.110
Coya Therapeutics Cash Per Share ttm
202403 202404 00.320.650.971.291.621.942.26
Coya Therapeutics P/S ratio ttm
202403 202404 03.316.629.9313.2416.5419.8523.16
Coya Therapeutics (GAAP) P/E ratio ttm
202403 202404 -17.77-15.23-12.69-10.15-7.61-5.08-2.540
Coya Therapeutics P/B ratio ttm
202403 202404 00.561.111.672.232.793.343.9
No extra charts and metrics for this ticker.